Greenhouse gas accounting sector guidance for pharmaceutical products and medical devices

The objective of the guidance is to enable consistent quantification of the GHG inventory of pharmaceutical products and medical devices. It is relevant for all pharmaceutical products and medical devices manufactured and administered in any country. To address this variability as well as the wide range of potential production and use pathways across the pharmaceutical and medical devices sector, the guidance uses a modular approach. The guidance addresses life cycle stages and processes in order to build a full life cycle profile for any type of pharmaceutical products or medical devices.

Link to external pdf